MDNews - Cleveland-Akron-Canton

November/December 2018

Issue link: http://viewer.e-digitaledition.com/i/1062971

Contents of this Issue

Navigation

Page 16 of 23

When taking care of patients is only part of the equation, you want a top-ranked law firm. WE DO OUR JOB SO YOU CAN DO YOURS. Our team of health care attorneys have the knowledge and experience to understand the current challenges confronting physicians and health care businesses. We do what we do, so you can focus on medicine. We advise and counsel health care providers in all areas of their business: • HIPAA compliance • Fraud and abuse compliance • Employment contracts • Mergers and acquisitions • Corporate compliance for non-profits • Affordable Care Act • Employment matters, including contracts, OSHA and workers' compensation • Supplier, third-party provider and insurance provider agreements • Practice formation and operation 4775 Munson Street NW | Canton, Ohio 44718 877.876.9958 | 330.497.0700 Offices Throughout Ohio KWGD.com CORE ElECTROCONVUlSIVE THER APY (ECT) YIElDS REMISSION R ATES OF ClOSE TO 70 PERCENT FOR ClINICAllY DEPRESSED PATIENTS WHO HAVE NOT RESPONDED TO ANTIDEPRESSANTS. HOWE VER, IT CAN CAUSE SIDE EFFECTS, INClUDING CONFUSION AND RE TROGR ADE AMNESIA. NOW KETAMINE — a genera l anesthetic that has a reputation a s a pa r t y dr ug — ha s ga ined at tention for its potentia l to treat depression a mong those for whom other approaches have fa iled. Clevela nd Clinic resea rchers a re leading a study compa ring the effectiveness a nd side effects of ECT to those of keta mine. They a nd scientists from Ya le Universit y, Baylor College of Medicine a nd Ica hn School of Medicine at Mount Sina i in New York are tracking 400 patients with treatment-resistant depression. Par ticipants will receive ECT three times a week or infusions of keta mine twice a week, Cleveland Magazine repor ts. The nea rly $12 mi llion study w i ll a ssess ef f icacy a nd side effects over a two-yea r period. " Hopef u lly we ca n lea rn what kinds of patients seem to respond best, what regimen we ca n use to help them respond optimally and what impact that can have," Donald Malone, MD, Clevela nd Clinic's Chair of the Center for Behaviora l Hea lth, told the ma ga zine. "About 10 percent of ever ybody ha s a n episode of depression sometime in their lifetime. If you rea lize about 20 percent of those patients who do have depression don't respond ver y well to our traditiona l treatments, that leaves huge numbers of individua ls who a re suffering." n Ketamine Eyed as TREATMENT FOR DEPRESSION BY STEVE BARRETT M D N E W S . C O M /// M D N E W S C l E V E l A N D /A K R O N / C A N T O N ■ N O V E M B E R / D E C E M B E R 2 018 1 7

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - November/December 2018